
Protai is an AI-powered drug discovery startup that leverages a deep understanding of protein networks, post-translational modifications, and complex structures to revolutionize disease treatment. Their AIMS™ platform integrates structural and functional proteomics data with AI to perform advanced protein simulations, identify novel drug mechanisms, and discover best-in-class drug candidates. The platform enables target redefinition by mapping cell-type specific protein states, allowing for selective inhibition of disease-relevant activities while preserving beneficial functions. Protai focuses on oncology and immunology, with a drug pipeline open for partnering. They aim to accelerate drug discovery by modeling disease-specific protein conformations and computationally designing modulators for redefined targets.

Protai is an AI-powered drug discovery startup that leverages a deep understanding of protein networks, post-translational modifications, and complex structures to revolutionize disease treatment. Their AIMS™ platform integrates structural and functional proteomics data with AI to perform advanced protein simulations, identify novel drug mechanisms, and discover best-in-class drug candidates. The platform enables target redefinition by mapping cell-type specific protein states, allowing for selective inhibition of disease-relevant activities while preserving beneficial functions. Protai focuses on oncology and immunology, with a drug pipeline open for partnering. They aim to accelerate drug discovery by modeling disease-specific protein conformations and computationally designing modulators for redefined targets.